Divergent effects of ethinylestradiol––drospirenone and flutamide––metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess

Author： Ibááññez Lourdes   Dííaz Marta   Lóópez-Bermejo Abel   de Zegher Francis  

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.27, Iss.3, 2011-03, pp. : 197-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ethinylestradiol/Drospirenone: A Review of its Use as an Oral Contraceptive

By Keam S.J.   Wagstaff A.J.  

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 39-61

Adis International

Access to resources Recommend Favorite

Flutamide–metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity

By Ibáñez Lourdes  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1725-1727

Oxford University Press

Access to resources Recommend Favorite

Discontinuous low-dose flutamide–metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-α and the neutrophil/lymphocyte ratio

By Ibáñez Lourdes   Valls Carme   de Zegher Francis  

Human Reproduction, Vol. 21, Iss. 2, 2006-02 ,pp. : 451-456

Oxford University Press

Access to resources Recommend Favorite

Androgen Excess Disorders in Women

By Mehta A.E.  

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 3, 1998-04 ,pp. : 129-130

Elsevier

Access to resources Recommend Favorite

Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome

By Loverro G.   Lorusso F.   De Pergola G.   Nicolardi V.   Mei L.   Selvaggi L.  

Gynecological Endocrinology, Vol. 16, Iss. 3, 2002-06 ,pp. : 217-224

Informa Healthcare

Access to resources Recommend Favorite